MyAverix Finance
NS · Pharmaceuticals
Panacea Biotec Ltd (PANACEABIO)
Pharmaceuticals & Biotechnology
Panacea Biotec Ltd (PANACEABIO) is listed on NS in the Pharmaceuticals sector. Industry: Pharmaceuticals & Biotechnology. As of 2026-07-07, reported market cap is $33.75B, P/E ratio is -112.91, net margin is -3.6%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for PANACEABIO
Panacea Biotec Ltd (PANACEABIO) — FAQ
What is Panacea Biotec Ltd's market cap?
Panacea Biotec Ltd (PANACEABIO) has a reported market cap of $33.75B (data as of 2026-07-07).
What is PANACEABIO's P/E ratio?
The price-to-earnings (P/E) ratio for Panacea Biotec Ltd (PANACEABIO) is -112.91 (data as of 2026-07-07).
Does Panacea Biotec Ltd pay a dividend?
Dividend yield is not available in the current snapshot for Panacea Biotec Ltd (PANACEABIO). Check the MyAverix Finance app for the latest dividend data.
What sector is Panacea Biotec Ltd in?
Panacea Biotec Ltd (PANACEABIO) is classified in the Pharmaceuticals sector (Pharmaceuticals & Biotechnology industry).
What exchange is PANACEABIO listed on?
PANACEABIO is listed on NS.
What is Panacea Biotec Ltd's net margin?
Panacea Biotec Ltd (PANACEABIO) reports a net margin of -3.6% (data as of 2026-07-07).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.